Ranibizumab for choroidal neovascular membrane in a rare case of Bietti′s crystalline dystrophy: A case report
Authors:
Open Access
- 1 January 2012
- journal article
- case report
- Published by Medknow in Indian Journal Of Ophthalmology
- Vol. 60 (3) , 207-9
Abstract
We report a rare case of Bietti's crystalline dystrophy presenting with choroidal neovascular membrane (CNVM) which was treated with three injections of intravitreal ranibizumab. The CNVM underwent scarring after the injections with stabilization of visual acuity at a follow-up period of 12 months suggesting that intravitreal ranibizumab may have a role in the management of CNVM in these rare cases.Keywords
This publication has 7 references indexed in Scilit:
- Ranibizumab for subfoveal choroidal neovascularization in Bietti crystalline retinopathyEye, 2010
- S156C Mutation in Tissue Inhibitor of Metalloproteinases-3 Induces Increased AngiogenesisJournal of Biological Chemistry, 2009
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trialsBritish Journal of Ophthalmology, 2009
- Subfoveal choroidal neovascularization in a 3-year-old child with North Carolina macular dystrophyJournal of American Association for Pediatric Ophthalmology and Strabismus, 2007
- Long-Term Follow-Up in Bietti Crystalline DystrophyEuropean Journal of Ophthalmology, 2007
- Choroidal neovascularisation secondary to Best’s disease in a 13-year-old boy treated by intravitreal bevacizumabGraefe's Archive for Clinical and Experimental Ophthalmology, 2007
- Bietti's Crystalline DystrophyArchives of Ophthalmology (1950), 1989